Pfizer Inc. (BVMF:PFIZ34)
Brazil · Delayed Price · Currency is BRL 33.99
-0.16 (-0.47%)
Last updated: Oct 9, 2025, 1:23 PM GMT-3
Pfizer Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2010 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 29, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2010 - 2019 |
Net Income | 10,768 | 8,051 | 2,173 | 31,401 | 22,459 | 6,666 | Upgrade |
Depreciation & Amortization | 6,789 | 7,013 | 6,290 | 5,064 | 5,191 | 4,681 | Upgrade |
Stock-Based Compensation | 824 | 877 | 525 | 872 | 1,182 | 755 | Upgrade |
Other Adjustments | -93 | -132 | 1,886 | -2,431 | -8,713 | -1,253 | Upgrade |
Change in Receivables | - | -109 | 347 | 261 | -3,811 | -1,275 | Upgrade |
Changes in Inventories | - | -854 | -1,169 | -591 | -1,125 | -778 | Upgrade |
Changes in Accounts Payable | - | -1,023 | -300 | 1,191 | 1,242 | 355 | Upgrade |
Changes in Income Taxes Payable | - | -1,345 | -982 | -545 | -1,166 | -1,240 | Upgrade |
Changes in Other Operating Activities | -37 | 265 | -68 | -5,955 | 17,321 | 6,494 | Upgrade |
Operating Cash Flow | 15,188 | 12,744 | 8,700 | 29,267 | 32,580 | 14,403 | Upgrade |
Operating Cash Flow Growth | 89.73% | 46.48% | -70.27% | -10.17% | 126.20% | 14.42% | Upgrade |
Capital Expenditures | -2,750 | -2,909 | -3,907 | -3,236 | -2,711 | -2,226 | Upgrade |
Purchases of Investments | -15,122 | -10,313 | -31,178 | -38,297 | -39,525 | -14,402 | Upgrade |
Proceeds from Sale of Investments | 11,249 | 15,874 | 46,417 | 44,979 | 20,008 | 12,730 | Upgrade |
Payments for Business Acquisitions | - | - | -43,430 | -22,997 | - | - | Upgrade |
Other Investing Activities | 308 | 2 | -179 | 3,768 | -317 | -374 | Upgrade |
Investing Cash Flow | 3,545 | 2,652 | -32,278 | -15,783 | -22,546 | -4,271 | Upgrade |
Short-Term Debt Issued | - | 8,907 | 4,525 | 3,891 | - | 12,352 | Upgrade |
Short-Term Debt Repaid | -8,573 | -13,816 | 3,158 | -4,109 | -96 | -26,326 | Upgrade |
Net Short-Term Debt Issued (Repaid) | -8,573 | -4,909 | 7,683 | -218 | -96 | -13,974 | Upgrade |
Long-Term Debt Issued | - | - | 30,831 | - | 997 | 5,222 | Upgrade |
Long-Term Debt Repaid | - | -2,250 | -2,569 | -3,298 | -2,004 | -4,003 | Upgrade |
Net Long-Term Debt Issued (Repaid) | - | -2,250 | 28,262 | -3,298 | -1,007 | 1,219 | Upgrade |
Repurchase of Common Stock | - | - | - | -2,000 | - | - | Upgrade |
Net Common Stock Issued (Repurchased) | - | - | - | -2,000 | - | - | Upgrade |
Common Dividends Paid | -9,642 | -9,512 | -9,247 | -8,983 | -8,729 | -8,440 | Upgrade |
Other Financing Activities | -397 | -469 | -631 | -335 | 16 | 11,547 | Upgrade |
Financing Cash Flow | -18,173 | -17,140 | 26,066 | -14,834 | -9,816 | -9,649 | Upgrade |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 14 | -66 | -40 | -165 | -59 | -8 | Upgrade |
Net Cash Flow | 572 | -1,810 | 2,448 | -1,515 | 159 | 475 | Upgrade |
Beginning Cash & Cash Equivalents | 1,123 | 2,917 | 468 | 1,983 | 1,825 | 1,350 | Upgrade |
Ending Cash & Cash Equivalents | 1,694 | 1,107 | 2,917 | 468 | 1,983 | 1,825 | Upgrade |
Free Cash Flow | 12,438 | 9,835 | 4,793 | 26,031 | 29,869 | 12,177 | Upgrade |
Free Cash Flow Growth | 26.47% | 105.19% | -81.59% | -12.85% | 145.29% | 15.51% | Upgrade |
FCF Margin | 19.49% | 15.46% | 8.05% | 25.73% | 36.74% | 29.24% | Upgrade |
Free Cash Flow Per Share | 2.18 | 1.73 | 0.84 | 4.54 | 5.23 | 2.16 | Upgrade |
Levered Free Cash Flow | 6,159 | 2,008 | 37,943 | 23,776 | 40,063 | 1,162 | Upgrade |
Unlevered Free Cash Flow | 14,772 | 9,198 | 2,037 | 27,327 | 41,211 | 13,953 | Upgrade |
Updated Jun 29, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.